+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Commercial Biotechnology Separation Systems: Global Strategic Business Report

  • PDF Icon

    Report

  • 273 Pages
  • September 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 3619383

Quick Summary:

In this dynamic business landscape, staying ahead of the curve requires timely and accurate market insights. The global commercial biotechnology separation systems market serves as a perfect example, expected to reach a staggering US$31 Billion by 2030. With an expansive outlook on such a high-growth market, our new market research report is a crucial investment for ambitious senior executives and decision-makers.

Our meticulously crafted report dives deep into the conventional and modern segments of this flourishing market. Not just limited to a global outlook, it offers an in-depth analysis of sizable economies like the U.S. and China, alongside significant others such as Japan, Canada, and Germany. We reveal key insights that outline potential opportunities pervading through these markets.

The report also features a comprehensive evaluation of 46 market competitors, illuminating their strategic positioning and competitive strength. Plus, gain exclusive access to our digital archives, research platforms and enjoy complimentary updates for a year, all powered by our commitment to keep you informed and prepared in an ever-evolving market landscape.

Global Commercial Biotechnology Separation Systems Market to Reach $31 Billion by 2030

The global market for Commercial Biotechnology Separation Systems estimated at US$24.6 Billion in the year 2022, is projected to reach a revised size of US$31 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2022-2030. Conventional, one of the segments analyzed in the report, is projected to record 2.7% CAGR and reach US$19 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Modern segment is readjusted to a revised 3.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 4.8% CAGR

The Commercial Biotechnology Separation Systems market in the U.S. is estimated at US$6.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 2.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR.

Select Competitors (Total 46 Featured) -

  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Commercial Biotechnology Separation Systems

What is the estimated value of the Global Market for Commercial Biotechnology Separation Systems?

The Global Market for Commercial Biotechnology Separation Systems was estimated to be valued at $24.6 Billion in 2022.

What is the growth rate of the Global Market for Commercial Biotechnology Separation Systems?

The growth rate of the Global Market for Commercial Biotechnology Separation Systems is 2.9%, with an estimated value of $31 Billion by 2030.

What is the forecasted size of the Global Market for Commercial Biotechnology Separation Systems?

The Global Market for Commercial Biotechnology Separation Systems is estimated to be worth $31 Billion by 2030.

Who are the key companies in the Global Market for Commercial Biotechnology Separation Systems?

Key companies in the Global Market for Commercial Biotechnology Separation Systems include 3M Company, AB Sciex, Agilent Technologies, Inc., Alfa Laval AB, Alfa Wassermann Separation Technologies LLC, Beckman Coulter Inc., Becton Dickinson and Company, Bio, Rad Laboratories Inc. and Flottweg SE.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Separation Technologies Drive Biotechnology Industry
  • Recent Market Activity
  • Developed Markets Lead the Way while Emerging Markets Promise Growth
  • DNA Microarrays - Largest & Fastest Growing Segment
  • Liquid Chromatography - One of the Leading Biotechnology Separation Technologies
  • Factors Sustaining Market Growth
  • Factors Restraining Growth
  • Commercial Biotechnology Separation Systems - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • 3M (USA)
  • AB Sciex LLC (USA)
  • Agilent Technologies, Inc. (USA)
  • Alfa Laval AB (Sweden)
  • Alfa Wassermann Separation Technologies, LLC (USA)
  • Beckman Coulter, Inc. (USA)
  • Becton, Dickinson and Company (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Flottweg SE (Germany)
  • Fluidigm Corporation (USA)
  • GE Healthcare (USA)
  • Groupe Novasep (France)
  • Hitachi High-Technologies Corp. (Japan)
  • Illumina, Inc. (USA)
  • Merck KGaA (Germany)
  • Pall Corporation (USA)
  • PerkinElmer, Inc. (USA)
  • ProMetic Life Sciences, Inc. (Canada)
  • Repligen Corporation (USA)
  • Sartorius Stedim Biotech SA (France)
  • SEPMAG (Spain)
  • Shimadzu Scientific Instruments (USA)
  • Sysmex Partec GmbH (Germany)
  • Thermo Fisher Scientific, Inc. (USA)
3. MARKET TRENDS & DRIVERS
  • Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing
  • A Peek into Biopharmaceutical Manufacturing
  • Downstream Processing of Biosynthetic Products - An Overview
  • Surging Biopharmaceutical Market Spurs Demand for Bioseparation Systems
  • New Biologic License Application (BLA) Approvals: 2017
  • New Biologic License Application (BLA) Approvals: 2016
  • New Biologic License Application (BLA) Approval: 2015
  • Evolving Biopharmaceutical Industry Emphasizes on Novel Technologies
  • Increasing Emphasis on Personalized Medicine Drives Market Growth
  • Rise in Healthcare Spending Bodes Well for Market Growth
  • Aging Population Drives Biotechnology Separation Systems Market
  • Global Aging Population Statistics - Opportunity Indicators
  • Increasing Incidence of Cancer Drives Biotechnology Separation Systems Market
  • Increasing Competition Spurs Renewed Focus on Efficiencies
  • Growing Orphan Drugs Market Draws Attention towards Manufacturing Flexibility
  • Downstream Processing - A Major Trend among Biopharmaceutical Manufacturers
  • Upstream and Downstream Mismatch Turns Focus towards Innovative Technologies
  • Protein Separation in Biopharmaceutical Space Assumes Greater Significance
  • Growing Market for Monoclonal Antibodies - A Key Review of Current Status and Future Prospects
  • Approved Monoclonal Antibodies: 2014-2017
  • An Insight into Bioseparation of mAbs
  • Market Potential for Biosimilars - A Case for Substantial Demand for Separation Technologies
  • US Approved Biosimilars as of December 2017
  • Europe Approved Biosimilars as of December 2017
  • Patent Expiries Create Opportunities for Biosimilar Manufacturers
  • Patent Expiries of Major Biologics in the US and Europe
  • Huge Biopharmaceutical Pipeline - A Clear Indicator of Future Prospects
  • Disposables to Infuse Cost Effectiveness in Biopharmaceutical Production
  • Single-Use Products Gain Significant Attention
  • Market Prospects for Single-Use Disposable Technologies
  • Select Commercial Disposable/Single-Use Technologies by Process Technique
  • Innovations in Single-use Systems
  • Modular Bioprocessing - An Emerging Trend
  • Leachables and Extractables Trounce Enthusiasm around Disposables
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 3: World 18-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 6: World 18-Year Perspective for Conventional by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 9: World 18-Year Perspective for Modern by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 12: World 18-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Food & Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Food & Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 15: World 18-Year Perspective for Food & Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 18: World 18-Year Perspective for Agriculture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 21: World 18-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 22: World Commercial Biotechnology Separation Systems Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
AUSTRALIA
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.